MAPT and Alzheimer disease: Elevated levels of tau reflect neuronal damage, and studies have shown that elevated levels of t-tau and p-tau181 in the CSF reflect degenerative processes in cortical regions typically involved in AD, however, p-tau181 associated with neurodegenerative changes in early AD may be more specific (Thomann et al., 2009).